Roche’s Virtual Event following Angiogenesis 2022
Roche has hosted a virtual event on Monday, 14 February 2021.
| Agenda | |
|---|---|
| Welcome | Bruno Eschli, Head of Investor Relations |
| Ophthalmology franchise strategy | Nilesh Mehta, Global Franchise Head, Ophthalmology |
| Ophthalmology clinical development | Christopher Brittain, Vice President and Global Head of Ophthalmology Product Development |
| Angiogenesis highlights | 2-Year data for Susvimo in nAMD (Ph III Archway), 2-Year data for Vabysmo in DME (Ph III YOSEMITE & RHINE), Nancy Holekamp, M.D., Retina Specialist |
| Q&A |
Webinar Replay
Investors